Your Article Summary
Angiotech pharmaceuticals announces the commercial launch of
the option inferior vena cava filter in the united states
Angiotech Pharmaceuticals, 08/21/09
Angiotech Pharmaceuticals, Inc. , announced the commercial launch of the Option Inferior Vena Cava Filter in the United States, following FDA 510 clearance in June and a limited pre–launch in July. Angiotech holds exclusive worldwide rights to market and distribute the Option IVC Filter, which it obtained in a license agreement with privately held Rex Medical, LP, as announced in March 2008.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Inno Biologics and CEVEC Sign License Agreement for Human CAP Technology
b3c newswire, 12/09/09
Federal Advisory Committees to Meet
HealthDataManagement, 12/09/09
Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR
Mylan, 12/09/09
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase III Data Showed Rituxan Plus Chemotherapy Improved Survival in Patients With Most Common Form of Adult Leukemia
Genentech, 12/08/09
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09
Article Search
Sponsor


See Latest Articles


